1. Home
  2. MLGO vs LTRN Comparison

MLGO vs LTRN Comparison

Compare MLGO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroAlgo Inc.

MLGO

MicroAlgo Inc.

HOLD

Current Price

$3.44

Market Cap

49.9M

Sector

Technology

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$1.50

Market Cap

27.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLGO
LTRN
Founded
2018
2013
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
27.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MLGO
LTRN
Price
$3.44
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.7K
158.1K
Earning Date
04-01-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
$87,132,230.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.91
N/A
Revenue Growth
6.21
N/A
52 Week Low
$3.02
$1.11
52 Week High
$12.50
$4.70

Technical Indicators

Market Signals
Indicator
MLGO
LTRN
Relative Strength Index (RSI) 33.52 25.12
Support Level $3.29 $1.11
Resistance Level $4.42 $2.41
Average True Range (ATR) 0.23 0.15
MACD -0.04 -0.00
Stochastic Oscillator 13.83 0.00

Price Performance

Historical Comparison
MLGO
LTRN

About MLGO MicroAlgo Inc.

MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: